KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,100,603 | -37.2% | 870,547 | +3.9% | 0.00% | -50.0% |
| Q2 2023 | $19,270,497 | -51.3% | 838,212 | -37.2% | 0.00% | 0.0% |
| Q1 2023 | $39,547,230 | +87.3% | 1,334,702 | +57.8% | 0.00% | 0.0% |
| Q4 2022 | $21,117,312 | +197.8% | 846,046 | +159.8% | 0.00% | +100.0% |
| Q3 2022 | $7,090,000 | +3.8% | 325,686 | -6.1% | 0.00% | 0.0% |
| Q2 2022 | $6,828,000 | -91.6% | 346,784 | -82.0% | 0.00% | -85.7% |
| Q1 2022 | $81,419,000 | -45.4% | 1,923,889 | -18.0% | 0.01% | -36.4% |
| Q4 2021 | $149,044,000 | +7.7% | 2,347,527 | -0.4% | 0.01% | 0.0% |
| Q3 2021 | $138,380,000 | +30.7% | 2,355,807 | +7.9% | 0.01% | +37.5% |
| Q2 2021 | $105,848,000 | +15.8% | 2,182,429 | -7.2% | 0.01% | 0.0% |
| Q1 2021 | $91,411,000 | -39.6% | 2,352,338 | -3.7% | 0.01% | -38.5% |
| Q4 2020 | $151,408,000 | +107.2% | 2,442,060 | +8.0% | 0.01% | +85.7% |
| Q3 2020 | $73,068,000 | – | 2,261,468 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |